Comparison of Drug-Free Remission after the End of Phase III Trials of Three Different Anti-IL-23 Inhibitors in Psoriasis.
Chang-Yu HsiehFrancis Li-Tien HsuTsen Fang TsaiPublished in: Dermatology and therapy (2024)
ClinicalTrials.gov identifiers NCT02694523, NCT03047395, NCT02207224, NCT02576431, NCT03482011, and NCT03556202.